Will NIH Ban on Consulting Deals with Drug Firms Set an Ethical Example? LAT / NYT Wed, 2 Feb 2005 The Los Angeles Times, whose investigative reports about conflicts of interest at the National Institutes of Health, shook the foundations of NIH by prying open the vaults that contained secret…
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.
"This is really an ethical Potemkin village, where a hollow system appears to provide the illusion of integrity, but transgressors never leave."
The Los Angeles Times has uncovered yet additional evidence of financial misconduct and corrupt practices at the National Institutes of Health (NIH).
Congressional leaders have lost patience with the cat and mouse game being played by officials of the National Institutes of Health.
The latest investigative report focusing on financial conflicts of interest by Pulitzer Prize winner, David Willman of the Los Angeles Times, reveals that even as the NIH director, Dr. Elias Zerhouni, announced publicly last year that scientists at the National Institutes of Health would be barred from accepting consulting fees from industry, evidence shows that the ban is clearly not being enforced.
Dr. Trey Sunderland III, chief of the geriatric psychiatry branch at the National Institute of Mental Health, pled the Fifth amendment.
Internal Investigation Found Widespread Ethical Lapses by NIH Scientists Thu, 14 Jul 2005 In a letter to Congfress, NIH director, Dr. Elias Zerhouni acknowledges: “We discovered cases of employees who consulted with research entities without seeking required approval, consulted in areas that appeared to conflict with their official duties, or…
Three Senior NIH Researchers in COI Controversy Are Leaving – LAT Thu, 10 Mar 2005 The Los Angeles Times reports that three senior NIH researchers whose paid consultancies are central to the heated controversy over professional / financial conflicts of interest are leaving. The revelations that sparked the controversy –…
NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ Sat, 5 Mar 2005 A group of dissident NIH scientists represented by an 18 member executive committee, are gripping about new rules prohibiting them from accepting fees for outside activities. Conflict of interest rules apply…
NIH to Ban Consulting Deals With Drug Firms – LAT / NYT Tue, 1 Feb 2005 Thanks to the investigative reports by David Willman in the Los Angeles Times, shedding light on secret financial ties by sernior scientists at the National Instiutes of Health, the public gained insight into the…
LA Times: NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling Fri, 22 Apr 2005 Pulitzer Prize winner David Willman of the Los Angeles Times, whose investigative reporting first revealed the major covert conflicts of interest among top scientists and administrators at the National Institutes of Health (NIH), reports…
